Home / Inspections / 1035442

FDA Inspection 1035442 — Chongqing Carelife Pharmaceutical Co., Ltd.

Chongqing Carelife Pharmaceutical Co., Ltd. — FEI 3011903543

The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on November 30, 2017 in Chongqing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 30, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chongqing (China)

Facility

Other inspections at this facility

  • 1268964 (NAI Fri Mar 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1098996 (NAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970028 (OAI Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851858 (VAI Fri Oct 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 684797 (VAI Fri Jul 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources